Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

CONCLUSION: Overall, quality assurance results were satisfactory and the CHHiP quality assurance programme contributed to the success of the trial by auditing radiotherapy treatment planning and protocol compliance. Quality assurance supported the introduction of IMRT in UK centres, giving additional confidence and external review of IMRT where it was a newly adopted technique. PMID: 31201110 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31201110?dopt=Abstract

Source: Clinical Prostate Cancer - June 10, 2019 Category: Cancer & Oncology Authors: Naismith O, Mayles H, Bidmead M, Clark CH, Gulliford S, Hassan S, Khoo V, Roberts K, South C, Hall E, Dearnaley D, CHHiP Investigators Tags: Clin Oncol (R Coll Radiol) Source Type: research